BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Returning to Boston for 2023\, the 2nd In Vivo Engineering of 
 Therapeutic Cells Summit is the only industry focused meeting place futur
 e innovations in the cell and gene space front and centre - dedicating ti
 me to explore the blockbuster potential of in vivo cell engineering with 
 a key focus on optimizing delivery\, targeting and specificity.\n\nGet ca
 ught up to speed on this dynamic industry with expertise shared from the 
 likes of Capstan Therapeutics\, Interius Biotherapeutics\, Vector Biophar
 ma and many others as the titans of industry unite to showcase the latest
  delivery technologies that are set to transform the cell and gene space.
 \n\nJoin your community of 100+ industry experts to revolutionise the fut
 ure of modern medicine\, bringing affordable and transformative cell ther
 apies to patients at need globally.\n\nURLs:Brochure:&nbsp\;https://go.ev
 vnt.com/1635974-2?pid=185Tickets:&nbsp\;https://go.evvnt.com/1635974-3?pi
 d=185\n\nPrices:Drug Developer - Conference + Workshop Day: USD 3296.00\,
 Drug Developer - Conference Only: USD 2099.00\,Academic - Conference + Wo
 rkshop Day: USD 2596.00\,Academic - Conference Only: USD 1699.00\,Service
  Provider - Conference + Workshop Day: USD 4296.00\,Service Provider - Co
 nference Only: USD 2799.00\n\nSpeakers:&nbsp\;Adi Barzel Professor\, Co-F
 ounder\, Tel Aviv University\, Logic Bio\, Tabby Therapeutics\, Adrian Bo
 t\, CSO\, Capstan Therapeutics\, Anna French\, Partner\, Qiming Venture P
 artners\, Artavazd Arumov\, VP\, Qiming Venture Partners\, Bakul Gupta CE
 O\, Co-Founder\, ImmTune Therapies Limited\, Cecile Bauche\, Founder\, CS
 O\, Alaya Bio\, Cory Sago\, CEO\, Stealth Mode Biotech\, David Johnson\, 
 CEO\, GigaMune\, David Peritt\, President and Co-Founder\, Lupagen\, Greg
 ory Newby\, Assistant Professor\, Johns Hopkins Department of Genetic Med
 icine\, Haig Aghajanian\, VP\, Research &nbsp\;Capstan Therapeutics\, Jag
 esh Shah\, VP\, Gene Therapy\, Sana Biotechnology\, James Edinger\, Senio
 r VP\, Preclinical Science\, Mustang Bio\, Lorenz Mayr\, CEO\, Vector Bio
 Pharma\, Mary Haak-Frendscho\, CEO\, Spotlight Therapeutics\, Mary Janatp
 our\, EVP and CSO\, Spotlight Therapeutics\, Owen Fenton\, Assistant Prof
 essor\, University of North Carolina\, Phil Johnson\, President and CEO\,
  Interius BioTherapeutics\, Renaud Vaillant\, President and Co-Founder\, 
 Alaya Bio\, Sheena Smith\, Head of Program Management\, Vector BioPharma\
 n\nTime:&nbsp\;8:30 am to 4:30 pm\n
DTEND:20230712T163000
DTSTAMP:20260512T232300Z
DTSTART:20230710T083000
LOCATION:Hyatt Regency Boston\, 1\, Avenue de Lafayette\, Boston\, Massach
 usetts\, 02111\,
SEQUENCE:0
SUMMARY:Returning to Boston for 2023\, the 2nd In Vivo Engineering of Ther
 apeutic Cells Summit is the only industry focused meeting place future in
 novations...
UID:fa375f24-90a0-492a-838a-db2be9842478
END:VEVENT
END:VCALENDAR